P38 map kinase mediates burn serum-induced endothelial barrier dysfunction: Involvement of F-actin rearrangement and L-caldesmon phosphorylation

Shock

Volumn 34, Issue 3, 2010, Pages 222-228

  Chu, Zhi Gang ^a   Zhang, Jia Ping ^a   Song, Hua Pei ^a   Hu, Jiong Yu ^a   Zhang, Qiong ^a   Xiang, Fei ^a   Huang, Yue Sheng ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

burn trauma; contractile force; cytoskeleton; endothelial permeability; Mitogen activated protein kinase

Indexed keywords

ALBUMIN; CALDESMON; F ACTIN; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; MITOGEN ACTIVATED PROTEIN KINASE P38;

ADENOVIRUS; ADULT; ARTICLE; BURN; CELL MEMBRANE PERMEABILITY; CELL STRUCTURE; CELL SURFACE; CONTROLLED STUDY; CYTOSKELETON; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; ENZYME ACTIVATION; FEMALE; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; MALE; MONOLAYER CULTURE; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SERUM; SHOCK; TIME; WESTERN BLOTTING;

ACTINS; BURNS; CALMODULIN-BINDING PROTEINS; CELL LINE; CELL MEMBRANE PERMEABILITY; CELLS, CULTURED; ENDOTHELIUM, VASCULAR; ENZYME ACTIVATION; HUMANS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; UMBILICAL VEINS;

EID: 77955959130     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/SHK.0b013e3181d8e357     Document Type: Article

References (33)

1. Breslin JW, Wu MH, Guo M, Reynoso R, Yuan SY: Toll-like receptor 4 contributes to microvascular inflammation and barrier dysfunction in thermal injury. Shock 29:349-355, 2008.
2. Tinsley JH, Teasdale NR, Yuan SY: Myosin light chain phosphorylation and pulmonary endothelial cell hyperpermeability in burns. Am J Physiol Lung Cell Mol Physiol 286:L841-L847, 2004.
3. Murphy JT, Duffy S, Purdue GF, Hunt JL: Differential activation of coronary and pulmonary endothelial cells by thermal injury. Shock 16:227-231, 2001.
4. Demling RH: The burn edema process: current concepts. J Burn Care Rehabil 26:207-227, 2005.
5. Murphy JT, Duffy S: ZO-1 redistribution and F-actin stress fiber formation in pulmonary endothelial cells after thermal injury. J Trauma 54:81-89, 2003.
6. Zheng HZ, Zhao KS, Zhou BY, Huang QB: Role of Rho kinase and actin filament in the increased vascular permeability of skin venules in rats after scalding. Burns 29:820-827, 2003.
7. Huang Q, Xu W, Ustinova E, Wu M, Childs E, Hunter F, Yuan S: Myosin light chain kinaseYdependent microvascular hyperpermeability in thermal injury. Shock 20:363-368, 2003.
8. Coulthard LR, White DE, Jones DL, McDermott MF, Burchill SA: p38 (MAPK): stress responses from molecular mechanisms to therapeutics. Trends Mol Med 15:369-379, 2009.
9. Costantini TW, Peterson CY, Kroll L, Loomis WH, Eliceiri BP, Baird A, Bansal V, Coimbra R: Role of p38 MAPK in burn-induced intestinal barrier breakdown. J Surg Res 156:64-69, 2009.
10. Zhang JP, Ying X, Liang WY, Luo ZH, Yang ZC, Huang YS, Wang WC: Apoptosis in cardiac myocytes during the early stage after severe burn. J Trauma 65:401-408, 2008.
11. Bruns B, Maass D, Barber R, Horton J, Carlson D: Alterations in the cardiac inflammatory response to burn trauma in mice lacking a functional Toll-like receptor 4 gene. Shock 30: 740-746, 2008.
12. Yuan SY: Protein kinase signaling in the modulation of microvascular permeability. Vascul Pharmacol 39:213-223, 2002.
13. Hai CM, Gu Z: Caldesmon phosphorylation in actin cytoskeletal remodeling. Eur J Cell Biol 85:305-309, 2006.
14. Borbiev T, Birukova A, Liu F, Nurmukhambetova S, Gerthoffer WT, Garcia JG, Verin AD: p38 MAP kinaseYdependent regulation of endothelial cell permeability. Am J Physiol Lung Cell Mol Physiol 287:L911-L918, 2004.
15. Bogatcheva NV, Birukova A, Borbiev T, Kolosova I, Liu F, Garcia JG, Verin AD: Caldesmon is a cytoskeletal target for PKC in endothelium. J Cell Biochem 99:1593-1605, 2006.
16. Bogatcheva NV, Wang P, Birukova AA, Verin AD, Garcia JG: Mechanism of fluoride-induced MAP kinase activation in pulmonary artery endothelial cells. Am J Physiol Lung Cell Mol Physiol 290:L1139-L1145, 2006.
17. Helfman DM, Levy ET, Berthier C, Shtutman M, Riveline D, Grosheva I, Lachish-Zalait A, Elbaum M, Bershadsky AD: Caldesmon inhibits nonmuscle cell contractility and interferes with the formation of focal adhesions. Mol Biol Cell 10:3097-3112, 1999.
18. Ward PA, Till GO: Pathophysiologic events related to thermal injury of skin. J Trauma 30:75-79, 1990.
19. Zhang JP, Ying X, Chen Y, Yang ZC, Huang YS: Inhibition of p38 MAP kinase improves survival of cardiac myocytes with hypoxia and burn serum challenge. Burns 34:220-227, 2008.
20. Yoshinari D, Takeyoshi I, Koibuchi Y, Matsumoto K, Kawashima Y, Koyama T, Ohwada S, Morishita Y: Effects of a dual inhibitor of tumor necrosis factor-alpha and interleukin-1 on lipopolysaccharide-induced lung injury in rats: involvement of the p38 mitogen-activated protein kinase pathway. Crit Care Med 29:628-634, 2001.
21. Aleshin A, Sawa Y, Ono M, Funatsu T, Miyagawa S, Matsuda H: Myocardial protective effect of FR167653: a novel cytokine inhibitor in ischemic-reperfused rat heart. Eur J Cardiothorac Surg 26:974-980, 2004.
22. Lu Q, Harrington EO, Jackson H, Morin N, Shannon C, Rounds S: Transforming growth factor-beta1-induced endothelial barrier dysfunction involves Smad2-dependent p38 activation and subsequent RhoA activation. J Appl Physiol 101:375-384, 2006.
23. Shivanna M, Rajashekhar G, Srinivas SP: Barrier dysfunction of the cor-neal endothelium in response to TNF-!: role of p38 MAP kinase. Invest Ophthalmol Vis Sci 51:1575-1582, 2010.
24. Birukova AA, Adyshev D, Gorshkov B, Birukov KG, Verin AD: ALK5 and Smad4 are involved in TGF-beta1-induced pulmonary endothelial permeability. FEBS Lett 579:4031-4037, 2005.
25. Breslin JW, Yuan SY: Involvement of RhoA and Rho kinase in neutrophil-stimulated endothelial hyperpermeability. Am J Physiol Heart Circ Physiol 286:H1057-H1062, 2004.
26. Campos SB, Ashworth SL, Wean S, Hosford M, Sandoval RM, Hallett MA, Atkinson SJ, Molitoris BA: Cytokine-induced F-actin reorganization in endo-thelial cells involves RhoA activation. Am J Physiol Renal Physiol 296: F487-F495, 2009.
27. Morigi M, Buelli S, Zanchi C, Longaretti L, Macconi D, Benigni A, Moioli D, Remuzzi G, Zoja C: Shigatoxin-induced endothelin-1 expression in cultured podocytes autocrinally mediates actin remodeling. Am J Pathol 169:1965-1975, 2006.
28. Wright K, Nwariaku F, Halaihel N, Schulman C, Yin HL, Turnage RH: Burn-activated neutrophils and tumor necrosis factor-alpha alter endothelial cell actin cytoskeleton and enhance monolayer permeability. Surgery 128:259-265, 2000.
29. Kayyali US, Pennella CM, Trujillo C, Villa O, Gaestel M, Hassoun PM: Cytoskeletal changes in hypoxic pulmonary endothelial cells are dependent on MAPK-activated protein kinase MK2. J Biol Chem 277:42596-42602, 2002.
30. Huot J, Houle F, Marceau F, Landry J: Oxidative stressYinduced actin reorganization mediated by the p38 mitogen-activated protein kinase/heat shock protein 27 pathway in vascular endothelial cells. Circ Res 80:383-392, 1997.
31. Borbiev T, Verin AD, Birukova A, Liu F, Crow MT, Garcia JG: Role of CaM kinase II and ERK activation in thrombin-induced endothelial cell barrier dysfunction. Am J Physiol Lung Cell Mol Physiol 285:L43-L54, 2003.
32. Kulikova N, Pronina OE, Dabrowska R, Borovikov YS: Caldesmon inhibits the actin-myosin interaction by changing its spatial orientation and mobility during the ATPase activity cycle. Biochem Biophys Res Commun 357: 461-466, 2007.
33. Reynoso R, Perrin RM, Breslin JW, Daines DA, Watson KD, Watterson DM, Wu MH, Yuan S: A role for long chain myosin light chain kinase (MLCK-210) in microvascular hyperpermeability during severe burns. Shock 28: 589-595, 2007.